The McDevitt Research Group
The McDevitt Group’s Mission is to make health care more affordable and more accessible on a global basis.
The laboratory has significant expertise in lab-on-a-chip sensors, clinical chemistry, micro-electro-mechanical (MEMs) devices, saliva-based diagnostics, programmable bio-nano-chip sensors, nanohealth and image-based sensors.
The research laboratory led by Professor John T. McDevitt has pioneered the development of powerful new medical microdevice sensor concepts that serve as the basis for a new universal platform for clinical chemistry testing. These micro-assay sensors yield both excellent performance characteristics as well as significant cost reduction.
These programmable bio-nano-chip sensor systems are now being evaluated in a broad range of clinical studies that target major diseases and health problems including cardiac, HIV immune function, cancer, drugs of abuse and trauma.
These efforts have been recognized by Science Coalition’s Best Scientific Advances for Year as well as the Popular Science's Best of What's New in the medical device category. The McDevitt lab has published over 170 peer-reviewed manuscripts, secured over 150 patents/patent applications thereby establishing one of largest patent portfolios in history of UT.
The group has recently moved to Rice University in the newly constructed $300M Bioscience Research Collaborative which is adjacent to the Texas Medical Center, the world’s largest medical complex. The McDevitt lab is active in translational activities and is involved in the creation of new standard methods that blend the best of electronics with the best of in vitro diagnostics en route to making more powerful, yet more affordable medical devices.
Visit a 360 of McDevitt Lab
McDevitt Lab Overview